Benzothiazinones Mediate Killing of Corynebacterineae by Blocking Decaprenyl Phosphate Recycling Involved in Cell Wall Biosynthesis by Grover, S. et al.
S. Besra
Lothar Eggeling, Apoorva Bhatt and Gurdyal
Mishra, Karin Krumbach, Jan Marienhagen, 
Shipra Grover, Luke J. Alderwick, Arun K.
  
Biosynthesis
Phosphate Recycling Involved in Cell Wall 
 by Blocking DecaprenylCorynebacterineae
Benzothiazinones Mediate Killing of 
Glycobiology and Extracellular Matrices:
doi: 10.1074/jbc.M113.522623 originally published online January 20, 2014
2014, 289:6177-6187.J. Biol. Chem. 
  
 10.1074/jbc.M113.522623Access the most updated version of this article at doi: 
  
.JBC Affinity SitesFind articles, minireviews, Reflections and Classics on similar topics on the 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/289/9/6177.full.html#ref-list-1
This article cites 34 references, 22 of which can be accessed free at
 at R
sch Cntr Julich Res library on O
ctober 15, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at R
sch Cntr Julich Res library on O
ctober 15, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Benzothiazinones Mediate Killing of Corynebacterineae by
Blocking Decaprenyl Phosphate Recycling Involved in Cell
Wall Biosynthesis*
Received for publication, September 26, 2013, and in revised form, January 20, 2014 Published, JBC Papers in Press, January 20, 2014, DOI 10.1074/jbc.M113.522623
Shipra Grover‡, Luke J. Alderwick‡, Arun K. Mishra‡1, Karin Krumbach§, Jan Marienhagen§, Lothar Eggeling§,
Apoorva Bhatt‡, and Gurdyal S. Besra‡2
From the ‡School of Biosciences, Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham B15
2TT, United Kingdom and the §Institute for Bio and Geosciences Biotechnology (IBG-1), Research Centre Juelich,
D-52425 Juelich, Germany
Background: Benzothiazinones inhibit cell wall arabinan biosynthesis, which is lethal for Corynebacterineae.
Results: Corynebacteria can evade the action of benzothiazinones in the absence of decaprenyl phosphoribose synthesis by
increasing the intracellular decaprenyl phosphate pool.
Conclusion: Benzothiazinones induce synthetic lethality in Corynebacterineae by blocking decaprenyl phosphate recycling.
Significance: Increased production of decaprenyl phosphate is a new mechanism of resistance to benzothiazinones.
Benzothiazinones (BTZs) are a new class of sulfur containing
heterocyclic compounds that target DprE1, an oxidoreductase
involved in the epimerization of decaprenyl-phosphoribose (DPR)
to decaprenyl-phosphoarabinose (DPA) in theCorynebacterineae,
such as Corynebacterium glutamicum andMycobacterium tuber-
culosis. As a result, BTZ inhibition leads to inhibition of cell wall
arabinan biosynthesis. Previous studies have demonstrated the
essentiality of dprE1. In contrast, Cg-UbiA a ribosyltransferase,
which catalyzes the first step of DPR biosynthesis prior to DprE1,
when genetically disrupted, produced a viable mutant, suggesting
that althoughBTZbiochemically targetsDprE1, killing alsooccurs
through chemical synthetic lethality, presumably through the lack
of decaprenyl phosphate recycling. To test this hypothesis, a deriv-
ative of BTZ, BTZ043, was examined in detail against C. glutami-
cumandC. glutamicum::ubiA. Thewild type strainwas sensitive to
BTZ043; however,C. glutamicum::ubiAwas found to be resistant,
despite possessing a functionalDprE1.When the gene encodingC.
glutamicum Z-decaprenyl-diphosphate synthase (NCgl2203) was
overexpressed in wild type C. glutamicum, resistance to BTZ043
was further increased. This data demonstrates that in the presence
of BTZ, the bacilli accumulate DPR and fail to recycle decaprenyl
phosphate, which results in the depletion of decaprenyl phosphate
and ultimately leads to cell death.
Tuberculosis (TB)3 remains the single most important bac-
terial cause ofmortality andmorbidity globally, causing 8.7mil-
lion new cases and 1.4 million deaths in 2011 (WHO, 2011).
Directly observed treatment, short course, amixture of anti-TB
drugs comprised of pyrazinamide, isoniazid, ethambutol, and
rifampicin, has been used successfully throughout the last three
decades as a treatment regimen for patients suffering from TB.
However, the emergence of multidrug resistant (MDR), exten-
sively drug-resistant (XDR), and now totally drug-resistant
strains ofMycobacterium tuberculosismeans that the need for
new drugs, delivery systems, and regimes for improved treat-
ment of TB is of paramount importance.
The sulfur-containing benzothiazinones (BTZ) have recently
been identified as a new class of highly potent anti-TB agents
(Fig. 1A), which display very low minimum inhibitory concen-
trations (MICs) forM. tuberculosis (1–4 ng/ml) and fast-grow-
ingMycobacterium species, such asMycobacterium smegmatis
(0.1–80 ng/ml) (1). Furthermore, BTZ exhibits high efficacy
against MDR and XDR-TB strains in addition to being non-
toxic toward human cell lines (2). Whole genome sequencing
studies of spontaneous mutants resistant to BTZ combined
with biochemical experiments established that BTZs target
DprE1 (Rv3790), which is a FAD-containing oxidoreductase
(Fig. 1B) that functions in concert with a NADH-dependent
reductase DprE2 (Rv3791) to catalyze the epimerization of
decaprenylphosphoryl-D-ribose (DPR) to decaprenylphosphoryl-
D-arabinose (DPA) (1, 3). DPR is first oxidized to a keto inter-
mediate, DPX via DprE1, and then reduced to DPA by DprE2.
The essentiality of DprE1 has been established inM. smegmatis
using a conditional mutant where the chromosomal copy of
dprE1 could be deleted only in the presence of a plasmid-en-
coded dprE1 copy (4). Similarly, attempts to delete the Coryne-
bacterium glutamicum orthologue, NCgl0187, have also been
unsuccessful (5). Interestingly, the decaprenylphosphoribose-
phosphate phosphatase (Rv3807) is not essential inM. tubercu-
losis (6) and redundancy is observed for DprE2 in C. glutami-
cum (5). The production of DPA and utilization in arabinan
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biosynthesis, as illustrated through genetic experiments and inac-
tivation ofdprE1, is therefore essential for the formation of a com-
pleteM. tuberculosis andC. glutamiucm cell wall (7).
The first step of the pathway for DPA biosynthesis is cata-
lyzed by UbiA, a ribosyltransferase that generates decaprenyl-
phosphoribose phosphate by condensation of phosphoribosyl
pyrophosphate with decaprenyl phosphate, followed by dephos-
phorylation (Rv3807) affording DPR. However, unlike in M.
tuberculosis, inactivation of ubiA in C. glutamicum produces a
viable mutant that is unable to synthesize DPA and is devoid of
cell wall arabinan, suggesting that synthesis of DPA and cell
wall arabinan itself is not essential for survival inC. glutamicum
(8, 9).
In this study, we examined the mode of action of BTZ inhi-
bition on C. glutamicum and C. glutamicum::ubiA. The data
shows that BTZ perturbs C. glutamicum growth but was inef-
fective against the Cg-UbiA mutant even though DprE1 was
functionally intact. In addition, the inhibitory effect of BTZ on
cell wall arabinan biosynthesis was examined when the C. glu-
tamicum Z-decaprenyl-diphosphate synthase, encoded by
NCgl2203 (UppS), was overexpressed in C. glutamicum. The
results demonstrate that overexpression of UppS was able to
rescue the wild type strain (BTZ MIC 20 g/ml) and shift the
MIC of BTZ for this strain to 40 g/ml. In conclusion, BTZ
blocks the recycling of decaprenyl phosphate as in its presence,
the cell continually synthesizes DPR, which is presumably toxic
to the cells, and subsequently renders decaprenyl phosphate
unavailable for the biosynthesis of other macromolecules, such
as peptidoglycan, lipoarabinomannan, and arabinogalactan.
However, the overexpression of a prenyl synthase supplements
enough decaprenyl phosphate to aid in cell wall biosynthesis.
EXPERIMENTAL PROCEDURES
Chemicals, Reagents, and Enzymes—All chemicals and sol-
vents were from Sigma, Bio-Rad, and Fisher Chemicals (UK),
unless otherwise stated, and were of AnalR grade or equivalent.
Plasmids were propagated during cloning in Escherichia coli
Top10 cells (Invitrogen). All restriction enzymes and Phusion
DNApolymerase enzymewere sourced fromNewEnglandBio-
labs. A Bioline quick ligation kit was used to perform ligation
reactions. Oligonucleotides were fromMWG Biotech Ltd. and
PCR fragments were purified using theQIAquick gel extraction
kit (Qiagen). Plasmid DNA was purified using the QIAprep
purification kit (Qiagen).
Bacterial Strains and Growth Conditions—E. coli Top 10
cells were routinely grown in Luria-Bertani broth (LB, Difco) at
37 °C. C. glutamicum ATCC 13032, C. glutamicum-pVWEx2,
andC. glutamicum-pVWEx2-uppS (10g/ml tetracycline) was
grown on rich brain heart infusionmedium (BHI, Difco) andC.
glutamicum::ubiA (25 g/ml of kanamycin) on BHI containing
9.1% sorbitol (BHIS) supplemented with appropriate antibi-
otics for selection.
Construction of Plasmids and Strains—C. glutamicum-uppS
(NCgl2203) was cloned in pVWEx2 under the isopropyl -D-
thiogalactopyranoside-inducible Ptac promoter andwas ampli-
fied from genomic DNA using the primers: 2203vwex, forward,
5-GCATGTCTAGAAGGAGATATAGATGTGAGTGAAT-
TCCAAGTA-3 and 2203vwex, reverse, 5-ATTAGGATCCT-
TATGCGCTTCCGAATCTGCG-3 (restriction sites under-
lined). The PCR product was ligated into plasmid pVWEx2
using XbaI and BamHI restriction sites, yielding C. glutami-
cum-pVWEx2-uppS. The empty pVWEx2 and pVWEx2-uppS
plasmids were electroporated intoC. glutamicum using a stand-
ard protocol (10). The pVWEx2-uppS plasmid was subsequently
sequenced by Eurofins MWGOperon. The C. glutamicum::ubiA
strain was obtained as described previously (8).
Expression of uppS in C. glutamicum—C. glutamicum-
pVWEx2-uppS cultureswere grownovernight and then used to
inoculate 50 ml of BHI (30 °C, 180 rpm, 10 g/ml of tetracy-
cline) and subsequently induced with 0.5 mM isopropyl -D-
thiogalactopyranoside at an A600 0.6 and incubated at 30 °C for
24 h. Cells were harvested (15 min, 7000  g), washed twice
with phosphate-buffered saline, and resuspended in 50 mM
MOPS (pH 7.9) containing lysozyme (0.2 mg/ml). The resus-
pended cell pellets were incubated at 37 °C for 1 h to allow cell
lysis. The suspension was centrifuged (20 min, 27,000  g, 20
min) and the supernatant checked for the presence of the
Cg-UppS protein on SDS-PAGE gels.
Effect of BTZ043 on C. glutamicum Strains—To determine
the C. glutamicum and C. glutamicum pVWEx2 MIC of
BTZ043, 108 cells were used to inoculate 2 ml of BHI broth
containing 0 to 20 g/ml of BTZ043 in a stepwise gradient and
the A600 measured up to 48 h. To determine the effect of
increasing concentrations of BTZ043 on C. glutamicum::ubiA
and C.glutamicum-pVWEx2-uppS, 108 cells were used
(30 °C, BHIS, 200 rpm) to inoculate 2 ml of BHIS containing 0
and 20g/ml of BTZ043 and theA600measured up to 48 h. The
cultures were also grown for 48 h as above and the viability
countwas determined by spotting 10l of serially diluted cultures
(up to dilution 108) on BHIS plates forC. glutamicum::ubiA and
C. glutamicum-pVWEx2-uppS.TheMICwas defined as themin-
imal concentration required to completely inhibit 99% of the
growth.
BTZ043 Inhibits DPA Synthesis in C. glutamicum Strains—
Tocharacterize the effect of BTZ043 onDprE1,p-[14C]Rppwas
synthesized as described previously (11) and supplemented as a
substrate for the in vitro synthesis of DPA. Accumulation of
DPR in the presence of BTZ043 was chosen as a parameter to
monitor the effect of BTZ043. Cell membranes from C. glu-
tamicum and C. glutamicum::ubiA were prepared as described
previously and assayed for DPA biosynthesis (12). Decaprenol
phosphate (50 g, 5 mg/ml stored in ethanol, 1 l) was dried
under nitrogen and resuspended in buffer A (50 mMMOPS, 10
mM MgCl2, pH 8.0) and sonicated. The basic assay mixture
consisted of 400 g of membranes and a P60 fraction (13), 25
mMATP, 25mMFAD, 25mMNAD, 25mMNADP, andBTZ043
(20 g/ml in DMSO) in a final volume of 80 l of buffer A and
initiated by the addition of 65,000 cpm of p-[14C]Rpp. Reac-
tions were incubated at 30 °C for 1 h and quenched by the addi-
tion of 4ml ofCHCl3/CH3OH/H2O (10:10:3, v/v) andmixed for
15min. The assaymixturewas combinedwith 1.75ml of CHCl3
and 0.75 ml of H2O, mixed for 15 min, and centrifuged at
3000 g for 10min. The lower organic phase was removed and
washed twice with 2 ml of CHCl3/CH3OH/H2O (3:47:48, v/v),
centrifuged at 3000 g for 15 min, recovered, and dried under
nitrogen. The resulting products were resuspended in 20 l of
Benzothiazinone-induced Synthetic Lethality
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CHCl3/CH3OH (2:1, v/v) and an aliquot was subjected to scin-
tillation counting using 5 ml of fluid, and a second aliquot was
subjected to TLC analysis using silica gel plates (5735 Silica Gel
60F254, Merck) developed in CHCl3/CH3OH/H2O/NH4OH/
CH3COONH4 (180:140:23:9:9, v/v), and visualized by phos-
phorimaging by exposing the TLCs to a phosphorimaging
screen (Kodak) for 24 h.
DprE1 IsFunctional inC. glutamicumandC. glutamicum::ubiA—
To characterize the effect of BTZ043 on DprE1, DP[14C]R was
supplemented as a substrate for the in vitro synthesis of
DP[14C]A (11). Cell membranes from C. glutamicum and C.
glutamicum::ubiA were assayed for DPA biosynthesis activity
as described previously. DP[14C]R was prepared using
p-[14C]Rpp as described previously (11). Briefly, to prevent
DPA formation, BTZ043 (20g/ml inDMSO)was added to the
assay in a final volume of 80 l (including buffer A, co-factor
mixture, membranes, and P60). The resulting DP[14C]R was
extracted as described previously and dried under nitrogen
(14). The resulting assay products were resuspended in 20l of
CHCl3/CH3OH (2:1, v/v) and an aliquot was subjected to TLC
analysis using silica gel plates (5735 Silica Gel 60F254, Merck)
developed in CHCl3/CH3OH/H2O/NH4OH/CH3COONH4
(180:140:23:9:9, v/v) and visualized by autoradiography by
exposure of TLCs to x-ray film (KodakX-Omat). TheDP[14C]R
thus prepared was used as a substrate for determining the func-
tionality of DprE1 in C. glutamicum and C. glutamicum::ubiA.
The basic assay mixture consisted of DP[14C]R (20,000 cpm)
dried and resuspended in buffer A, 500 g of membranes, and
P60 fraction, co-factor mixture and BTZ043 (20 g/ml in
DMSO) in a final volume of 80 l of buffer A. Reactions were
incubated at 30 °C for 1 h and quenched by the addition of 4 ml
of CHCl3/CH3OH/H2O (10:10:3, v/v), and mixed for 15 min.
The assay mixture was combined with 1.75 ml of CHCl3 and
0.75 ml of H2O, mixed for 15 min, and centrifuged at 3,000 g
for 10 min. The lower organic phase was removed and washed
twice with 2 ml of CHCl3/CH3OH/H2O (3:47:48, v/v), centri-
fuged at 3,000 g for 15min, recovered, and dried under nitro-
gen. The resulting residue was resuspended in 20 l of CHCl3/
CH3OH (2:1, v/v) and equal counts (10,000 cpm) were
subjected to TLC analysis using silica gel plates (5735 Silica Gel
60F254, Merck) developed in CHCl3/CH3OH/H2O/NH4OH/
CH3COONH4 (180:140:23:9:9, v/v) and visualized by phosphor-
imaging by exposing the TLCs to a phosphorscreen (Kodak) for
24 h.
Increased Synthesis of Decaprenyl Phosphate Occurs in C.
glutamicum-pVWEx2-uppS—To characterize the effect of
overexpression of the C. glutamicum decaprenyl-phosphate
synthase (UppS) on decaprenyl phosphate synthesis, [4-14C]-
isopentenyl pyrophosphate (IPP), and triammonium salt
(40–60 mCi/mmol, PerkinElmer Life Sciences) was supple-
mented as a substrate. Cell membranes from C. glutamicum-
pVWEx2 and C. glutamicum-pVWEx2-uppS were prepared as
described previously (12) and assayed for decaprenyl phosphate
biosynthesis activity.
[14C]IPP (30 M stored in ethanol) was dried under nitrogen
and resuspended in bufferAwith 400g ofmembranes, 100M
geranyl diphosphate, 100 M dimethyl allyl diphosphate, and
BTZ043 (20g/ml in DMSO), where required in a final volume
of 55 l of buffer A. Reactions were incubated at 30 °C for 1 h
and quenched by the addition of 1 ml of water-saturated NaCl
and extracted using butanol saturated with water. The butanol
fraction was dried under nitrogen and subjected to mild acid
hydrolysis using 0.1 N HCl in 50% ethanol at 37 °C for 24 h. The
radiolabeled dephosphorylated products were recovered by
addition of an equal volume of chloroform. The extracts were
washed twice with water and the organic phase was recovered,
dried, and resuspended in 20l of CHCl3/CH3OH (2:1, v/v). An
aliquot was taken for liquid scintillation counting and equal
counts (20,000 cpm) were subjected to TLC analysis using
reverse phase silica gel plates (Silica Gel 60 RP-18 F254S,
Merck) developed inmethanol/acetone (8:2, v/v) and visualized
by autoradiography by exposing the TLCs to x-ray film (Kodak
X-Omat) for 24 h and compared with known standards using
ethanolic molybdophosphoric acid and plates heated gently
using a heat-gun.
Analysis of AG and LAM Biosynthesis in C. glutamicum-
pVWEx2 and C. glutamicum-pVWEx2-uppS Treated with
BTZ043—To analyze the effect of overexpression of decapre-
nyl-phosphate synthase on the cell wall component AG in C.
glutamicum, overnight cultures of C. glutamicum-pVWEx2
and C. glutamicum-pVWEx2-uppS were used to subculture 20
ml of BHI media and grown toA600 0.4–0.6. The cultures were
induced with 0.5 mM isopropyl -D-thiogalactopyranoside and
half of the culture was treated with BTZ043 at 0.75 MIC
(15 g/ml) for 2 h. Both treated and untreated cultures were
labeled with 1.0 Ci/ml of [14C]glucose (250–360 mCi/mmol,
PerkinElmer Life Sciences) and grown for 48 h (30 °C, 200 rpm).
The mycolylarabinogalactan complex was isolated and sugar
hydrolysis was performed on all the samples as previously
described (15). The radioactive sugar samples were analyzed by
loading equal counts (20,000 cpm) on HPTLC-cellulose plates
developed three times in formic acid/water/tertiary butanol/
methylethyl ketone (3:3:8:6) and visualized by autoradiography
by exposing the TLC to x-ray film (Kodak X-Omat) for 4 days.
To analyze the effect of overexpression of decaprenyl-phos-
phate synthase on the cell wall component LAM/LM in C. glu-
tamicum, overnight cultures ofC. glutamicum-pVWEx2 andC.
glutamicum-pVWEx2-uppS were used to subculture 40 ml of
BHI media and grown to A600 0.4–0.6. The cultures were
induced with 0.5 mM isopropyl -D-thiogalactopyranoside and
labeled with 1.0 Ci/ml of [14C]glucose (250–360 mCi/mmol,
PerkinElmer Life Sciences) and grown for 1 h (30 °C, 200 rpm).
At time 0 h, the culture was split into 5-ml aliquots and BTZ043
(20 g/ml) was introduced into half of the aliquots to afford
treated and untreated cultures. The cultureswere then sampled
every 2 h by using 5-ml aliquots, centrifuged, and snap frozen
using liquid nitrogen. LAM/LM analysis was performed on all
the samples as previously described (8). The [14C]LAM/LM
samples were analyzed by loading equal counts (3000 cpm) on
SDS-PAGE gel and visualized by autoradiography by exposing
the gels to x-ray film (Kodak X-Omat) for 14 days.
RESULTS
Effect of BTZ043 on C. glutamicum Wild Type and C.
glutamicum::ubiA—The BTZ analog BTZ043 targets DprE1,
which is a FAD-containing oxidoreductase conserved across
Benzothiazinone-induced Synthetic Lethality
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the Corynebacterineae (14). Sequence alignment analysis of
Rv3790 and NCgl0187 (the open reading frames encoding
DprE1 from M. tuberculosis and C. glutamicum, respectively)
shows that the amino acid sequences of these two orthologs are
65% identical (5). Furthermore, Cg-DprE1 also contains all the
conserved active site residues, including Cys-414, which corre-
sponds to Cys-387 in Mt-DprE1 that forms a covalent semi-
mercaptal linkage with the activated nitroso group of BTZ043
(Fig. 1B). C. glutamicum andM. tuberculosis share very similar
cell wall architecture and due to its genetically tractable
genome, we have used C. glutamicum extensively as an excel-
lent model organism to study the molecular genetics of myco-
bacterial cell wall biosynthesis (8, 16, 17). C. glutamicum::ubiA
is a particularly interesting genetically modified strain, in as
much as it is completely devoid of arabinan in its cell wall. UbiA
encodes for a decaprenylphosphoryl-5-phospho--D-ribose
synthase and is non-essential in C. glutamicum. Because the
primary action of BTZ043 is reportedly due to the blockage of
cell wall arabinan biosynthesis, we cultured C. glutamicum
(wild type) andC. glutamicum::ubiA in liquidmedia over a 48-h
period and examined their susceptibility to BTZ043 at a range
of concentrations (Fig. 2, A and B). We determined that the
MIC of BTZ043 against wild type C. glutamicum is 20 g/ml
(Fig. 2A). Although C. glutamicum::ubiA is inherently slow
growing, when we repeated the experiment with this mutant,
we observed that BTZ043 failed to inhibit the growth of this
arabinan-deficient mutant at a concentration corresponding to
theMIC of the wild type strain (Fig. 2B). Furthermore, we con-
ducted cell viability assays against C. glutamicum and C.
glutamicum::ubiA against increasing concentrations of BTZ043;
our data demonstrates that BTZ043 elicits a 1000-fold decrease
in cell viability against C. glutamicum in comparison to C.
glutamicum::ubiA in which BTZ043 failed to inhibit its growth
with no observable effect on cell viability (Fig. 2C). Therefore, C.
glutamicum::ubiA was determined to be resistant to BTZ043, in
comparison with the sensitive wild typeC. glutamicum strain.
BTZ043 Inhibits DPA Synthesis in C. glutamicum and C.
glutamicum::ubiAwith a FunctionalDprE1—Wepreparedmem-
branepreparations fromC. glutamicum andC. glutamicum::ubiA,
whichwere subsequently examined for their ability to synthesize
DPA in the absence and presence of BTZ043. Initial experi-
ments used p-[14C]Rpp as an exogenous substrate with extracts
to monitor the conversion of p-[14C]Rpp to DP[14C]R and
DP[14C]A, which were evaluated using thin-layer chromatog-
raphy (TLC) followed by phosphorimaging (Fig. 3A). Analysis
of the 14C-labeled products by TLC clearly demonstrates that
C. glutamicum is able to utilize p-[14C]Rpp as a substrate and
synthesizeDP[14C]A (Fig. 3A, lane 3).However, this conversion
to DP[14C]A is inhibited when reaction mixtures are incubated
with BTZ043, affording only DP[14C]R (Fig. 3A, lane 2). We
FIGURE 1. Structure andmode of inhibition of BTZ043. A, structure of the antitubercular compound BTZ043 that targets DprE1. B, BTZ043 is reduced into a
nitroso-derivative by the flavin cofactor of DprE1 (36). This electrophilic nitroso-derivative irreversibly binds Cys-387 in the active site of DprE1 (14, 35, 36) and
forms a semi-mercaptal adduct that renders the enzyme inactive.
Benzothiazinone-induced Synthetic Lethality
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also performed control experiments that included known
standards (DPA, Fig. 3A, lane 1) and an enzyme blank (Fig. 3A,
lane 6). However, no 14C-labeled products were seen when
reactions were carried out using membranes prepared from C.
glutamiucm::ubiA either in the absence or presence of BTZ043
(Fig. 3A, lanes 4 and 5). The inability of C. glutamiucm::ubiA to
synthesize DPR/DPA is due to the absence of UbiA, which is a
decaprenylphosphoryl-5-phospho--D-ribose synthase and is
required for transfer of ribose 5-phosphate from p-[14C]Rpp to
the lipid carrier decaprenylmonophosphate, and represents the
first committed step to initiate synthesis of DPR/DPA (18).
To examine endogenous DprE1 activity directly in C. glu-
tamicum andC. glutamicum::ubiA, DP[14C]R was exogenously
supplied as a substrate in the absence and presence of BTZ043.
Reaction products were extracted, separated by TLC, and sub-
jected to analysis by phosphorimaging, which demonstrates
that DP[14C]A is capable of being synthesized in cell-free assays
frombothC. glutamicum andC. glutamicum::ubiA strains (Fig.
3B, lanes 2 and 4). Furthermore, the synthesis ofDPA is blocked
in the presence of BTZ043, thus indicating that both C. glu-
tamicum andC. glutamicum::ubiA express a functional copy of
DprE1 and is targeted effectively by BTZ043 (Fig. 3B, lanes
3 and 5). The apparent lack of BTZ043 inhibition of C.
glutamiucm::ubiA grown in culture is in stark contrast to the
effect of BTZ043 onwild typeC. glutamicum, and suggests that
its mode of action is not due solely to DprE1 inhibition. This
synthetic viable phenotype is manifested by the interruption of
ubiA in C. glutamicum, which serves to alleviate sensitivity
toward BTZ043. Because UbiA signifies the first committed
step in the biosynthetic pathway leading toward DPA forma-
tion, we hypothesized that the primary effect of BTZ043 was to
create a situation whereby exposure of C. glutamicum to the
drug causes an accumulation ofDPR,which is presumably toxic
to the cells. Subsequently, this results in a failure by the cell
to recycle decaprenyl phosphate and its limited availability
causes a severe growth phenotype in Corynebacterineae. This
BTZ043-induced chemical synthetic lethality is removed in C.
glutamicum::ubiA because decaprenylphosphoribose phos-
phate is not being produced as a precursor to DPR formation,
thus it allows the recycling of decaprenyl phosphate to occur
unhindered, which is required for cell wall peptidoglycan
biosynthesis.
Overexpression of Cg-uppS, a Prenylphosphate Synthase Pro-
tects C. glutamicum from Inhibition by BTZ043—The above
data suggests that a fine balance exists in terms of the supply of
decaprenyl phosphate for the biosynthetic pathways leading to
DPA and lipid II formation, which ultimately result in the for-
FIGURE 2. Comparison of growth, viability, and susceptibility to BTZ043
of C. glutamicum and C. glutamicum::ubiA. A, C. glutamicumwas examined
for its susceptibility to BTZ043 in liquidmedia at a range of concentrations (0,
1, 4, 10, and 20 g/ml). B, C. glutamicum::ubiA was examined for its suscepti-
bility to BTZ043 in liquidmedia at a final concentration of 20g/ml (MIC forC.
glutamicum).C, the cell viability ofC. glutamicum andC. glutamicum::ubiAwas
tested at a range of BTZ043 concentrations (0, 1, 5, 10, 15, and 20 g/ml) by
spotting108-109 cells on BHIS-agar plates incubated at 30 °C for 48 h after
treatment with 20 g/ml of BTZ043.
FIGURE 3. DprE1 is functionally active in C. glutamicum and C.
glutamicum::ubiA.Membrane and “P60” extracts were prepared from C. glu-
tamicum and C. glutamicum::ubiA and examined for their ability to generate
DP[14C]A from exogenously supplied p-[14C]Rpp (A) and DP[14C]R (B) in the
absence and presence of BTZ043 (20 g/ml). A, membrane and P60 extracts
fromC. glutamicum are capable of synthesizingDP[14C]Awhen suppliedwith
p-[14C]Rpp and were inhibited in assays that included BTZ043, whereas no
14C-labeled products were seen in preparations from C. glutamicum::ubiA
upon treatment with BTZ043. B, DprE1 activity was directly assessed by sup-
plementing DP[14C]R as a substrate. In the absence of BTZ043, both C. glu-
tamicum and C. glutamicum::ubiA were able to produce DP[14C]A, whereas
DP[14C]A formation was completely ablated when the assays were repeated
in the presence of BTZ043, suggesting the presence of a fully functional
DprE1 in C. glutamicum::ubiA.
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mation of AG and peptidoglycan, respectively. To further
investigate the role of decaprenyl phosphate in cell wall biosyn-
thesis, we overexpressed uppS (NCgl2203) (which encodes for a
decaprenylphosphate synthase) by transforming C. glutami-
cum with pVWEx2-uppS. The growth and viability of both C.
glutamicum-pVWEx2 and C. glutamicum-pVWEx2-uppS was
examined following exposure to BTZ043 in liquid media, with
both strains exhibiting comparable growth kinetics (Fig. 4A).
After culturing C. glutamicum-pVWEx2 and C. glutamicum-
pVWEx2-uppS in liquidmedia for 48 h in the absence and pres-
ence (1 and 2 MIC) of BTZ043, we measured end point
readings for optical density and cell viability (Fig. 4,B andC). As
expected BTZ043 inhibited the growth of C. glutamicum-
pVWEx2 at concentrations of 1 and 2 MIC, whereas C.
glutamicum-pVWEx2-uppS displayed a significantly increased
resistance to BTZ043with aMIC40g/ml (Fig. 4B). Further-
more, the viable counts forC. glutamicum-pVWEx2-uppSwere
significantly higher than C. glutamicum-pVWEx2 at the 1
MIC (20 g/ml) and 2 MIC (40 g/ml) of BTZ043, respec-
tively (Fig. 4C). The results demonstrated thatCg-UppS prenyl-
phosphate synthase, when overexpressed, could rescue C. glu-
tamicum-pVWEx2 from inhibition by BTZ043.
UppS Overexpression Results in an Increased Synthesis of
Decaprenyl Phosphate in C. glutamicum—We prepared mem-
brane extracts from C. glutamicum-pVWEx2 and C. glutami-
cum-pVWEx2-uppS, which were subsequently examined for
their ability to synthesize decaprenyl phosphate in the absence
and presence of BTZ043. We made use of [14C]IPP as an exog-
enous substrate suppliedwithmembrane and cytosolic extracts
tomonitor the conversion of [14C]IPP to [14C]decaprenyl phos-
phate, which was evaluated using TLC followed by phosphor-
imaging (Fig. 5). Analysis of the 14C-labeled products by TLC
clearly demonstrates that C. glutamicum is able to utilize
[14C]IPP as a substrate and synthesize [14C]decaprenyl phos-
phate (Fig. 5). We conducted a densitometric analysis of the
bands migrating on the TLC that correspond to decaprenyl
phosphate and then calculated the apparent and actual cpm
incorporated into [14C]decaprenyl phosphate from a total of
20,000 cpm loaded per reaction. C. glutamicum produced
481 72 cpm/g of protein, whereas overexpression ofuppS in
C. glutamicum increases the amount of [14C]decaprenyl phos-
phate by 77% (853 16 cpm/g of protein) and is illustrated by
the increase in density of the band migrating on a TLC, corre-
sponding to a standard decaprenyl phosphate (Fig. 5). When
assays were supplemented with 20 g/ml of BTZ043, synthesis
of the decaprenyl phosphate pool appears to reduce inwild type
C. glutamicum-pVWEx2 and remain relatively unchanged inC.
glutamicum-pVWEx2-uppS, when compared with assays con-
FIGURE 4. Effect of BTZ043 treatment on C. glutamicum-pVWEx2 and C.
glutamicum-pVWEx2-uppS. The growth and viability of C. glutamicum-
pVWEx2 and C. glutamicum-pVWEx2-uppS was examined in the presence of
BTZ043. A, the growth rates of both C. glutamicum and C. glutamicum-
pVWEx2-uppS were monitored in the absence of BTZ043 in liquid media for
48 h to check the effect of overexpression. B, the growth of C. glutamicum-
pVWEx2 and C. glutamicum-pVWEx2-uppS was measured in the presence of
BTZ043 at 1 MIC (20 g/ml) and 2 MIC (40 g/ml). The optical density
(A600) obtained for C. glutamicum-pVWEx2-uppS was higher than C. glutami-
cum-pVWEx2 at both 1MIC and 2MIC, indicating increased tolerance to
BTZ043. C, cell viability counts were determined for C. glutamicum-pVWEx2
and C. glutamicum-pVWEx2-uppS treated for 48 h at 1 and 2 MIC of
BTZ043 after plating on BHI-agar plates.
FIGURE 5. Overexpression of uppS in C. glutamicum elicits an increase in
decaprenyl phosphate synthesis. Cell-free extracts prepared from C. glu-
tamicum-pVWEx2 (Cg-pVWEx2) and C. glutamicum-pVWEx2-uppS (Cg-
pVWEx2-uppS) were examined for any increased biosynthesis of decaprenyl
phosphate in thepresence andabsenceof BTZ043 (20g/ml), by labeling the
assay mixtures with exogenous [14C]IPP. Assays were quenched after a 1-h
incubation at 30 °C and reaction products were extracted with organic sol-
vent. Equal counts (20,000 cpm) were loaded onto a reverse phase silica gel
plates (SilicaGel 60RP-18 F254S,Merck) developed inmethanol/acetone (8:2,
v/v) and visualized by phosphorimaging.
Benzothiazinone-induced Synthetic Lethality
6182 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 9•FEBRUARY 28, 2014
 at R
sch Cntr Julich Res library on O
ctober 15, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ducted in the absence of BTZ043 (Fig. 5). After normalizing the
cpm for the absolute total counts recovered in each of the
BTZ043-treated assays, we see a small, yet significant increase
in the synthesis of decaprenyl phosphate, which equates to 8
and 10% for C. glutamicum-pVWEx2 and C. glutamicum-
pVWEx2-uppS, respectively. Our data suggests that BTZ043
inhibition of endogenous DprE1 leads to a blockage in the DPA
biosynthetic pathway, which prevents recycling of decaprenyl
phosphate back into the cellular pool for the formation of deca-
prenyl phosphate-linked intermediates required for cell wall
biosynthesis.
Overexpression of UppS Restores Arabinogalactan Biosynthe-
sis in C. glutamicum Treated with BTZ043—To further assess
the effect of BTZ043 on incorporation of arabinose into the cell
wall, C. glutamicum-pVWEx2 and C. glutamicum-pVWEx2-
uppS were examined for their ability to synthesize AG when
treated with BTZ043 (Fig. 6). The mycolylarabinogalactan
peoptidoglycan complex (mAGP) was prepared from samples
collected at 48 h from BTZ043 (15 g/ml) treated and non-
treated cultures and subsequently analyzed for its sugar com-
position. The distribution of radioactivity was detected
between [14C]arabinose, [14C]mannose, and [14C]galactose
after separation by TLC followed by autoradiography. Chro-
matographic analysis showed that in C. glutamicum-pVWEx2
treated with BTZ043 (15 g/ml), incorporation of arabinose in
AG is significantly reduced, whereas the level of arabinose
being incorporated in C. glutamicum-pVWEx2-uppS remains
relatively unchanged upon exposure to BTZ043 (15 g/ml).
TLC analysis of our hydrolyzed cell wall preparations also
showed the presence of mannose, which we aportion to being
an impurity coming from LM and LAM contaminants. We
observe no notable difference in the galactan levels, which
remain unchanged when we compareC. glutamicum-pVWEx2
and C. glutamicum-pVWEx2-uppS either treated or untreated
with BTZ043 (Fig. 6). Thus, C. glutamicum-pVWEx2-uppS is
able to synthesize AG unhindered in the presence of BTZ043 at
0.75MIC.
Overexpression of UppS Restores LAM Biosynthesis in C. glu-
tamicum Treated with BTZ043—C. glutamicum-pVWEx2 and
C. glutamicum-pVWEx2-uppS were examined for their ability
to synthesize LAMwhen treated with BTZ043 (20 g/ml) (Fig.
7). Exponentially growing cultures of C. glutamicum-pVWEx2
and C. glutamicum-pVWEx2-uppS were treated with BTZ043
and samples were removed every 2 h fromBTZ043-treated cul-
tures (as well as non-treated cultures). Following lipoglycan
extraction, the presence of [14C]LAM was detected in SDS-
PAGEgels by autoradiography (Fig. 7). The SDS-PAGE analysis
showed that in C. glutamicum-pVWEx2 cultures treated with
BTZ043 (20g/ml), production of LAMandLM is significantly
reduced over time when compared with untreated cultures of
C. glutamicum-pVWEx2 (Fig. 7, A and B). However, modest
levels of LAM and LM are still being produced in C. glutami-
cum-pVWEx2-uppS upon exposure to BTZ043 (20 g/ml), as
shown at 6 h when compared with both C. glutamicum-
pVWEx2 and C. glutamicum-pVWEx2-uppS treated with
BTZ043 (Fig. 7,C andD). Thus,C. glutamicum-pVWEx2-uppS
is able to continually synthesize LAM in the presence of
BTZ013 at 2MIC.
DISCUSSION
In 2009, it was reported that a new class of compounds called
benzothiazinones exhibit extremely potent bactericidal activity
againstM. tuberculosis, as well as against drug-resistant clinical
isolates, such as MDR-TB and XDR-TB strains (1). The most
active compound, BTZ043, was shown by both biochemical
and genetic experiments to target DprE1, a FAD-containing
oxidoreductase responsible for the conversion of DPR to DPX
(Fig. 8). Recently, the x-ray crystal structure of DprE1 in com-
plex with BTZ043 was solved, highlighting the importance of a
reactive Cys-387 residue in the active site, which forms a cova-
lent semi-mercaptal linkage with the nitroso group of the mol-
ecule (Fig. 1B), thus providing the structural basis for suicide
inhibition of DprE1 by BTZ (14, 19). DprE2 is a NADH-depen-
dent reductase, which partners DprE1 as an “epimerization
pair” that serves to reduce DPX to DPA (3). DPA is the sole
substrate that is utilized by an array of membrane-embedded
arabinofuranosyltransferases that are responsible for assem-
bling the D-arabinan, which is an essential domain that is cova-
lently attached to both LMand linear galactan, ultimately form-
ing LAM and AG, respectively. EmbA, EmbB, and EmbC are
three such arabinofuranosyltransferasess that are responsible,
in part, for the biosynthesis of D-arabinan; each of these
enzymes are targeted by ethambutol, a front-line drug currently
in clinical use as part of the directly observed treatment, short
course regimen (20, 21). However, due to the potency of
BTZ043, DprE1 has been lauded by many within the mycobac-
terial research community as a “magic drug target.” Targeting
D-arabinan biosynthesis ultimately results in the removal of
covalent linkage between peptidoglycan and the outermycolate
layers, and is a salutary approach to development of new anti-
mycobacterial agents. However, this is insufficient evidence to
explain the vulnerable nature of DprE1 as a magic drug target,
sitting at a critical intersection of cell wall biosynthesis. We
sought to investigate the vulnerability of DprE1 as a drug target
and the results from this study serve to deconvolute the obser-
FIGURE 6. Effect of BTZ043 onAGbiosynthesis in C. glutamicum-pVWEx2
and C. glutamicum-pVWEx2-uppS. The radioactive mAGP extracts were
prepared from treated and untreated cultures of C. glutamicum-pVWEx2 (Cg-
pVWEx2) and C. glutamicum-pVWEx2-uppS (Cg-pVWEx2-uppS) after 48 h of
treatment with 0.75 MIC BTZ043 (15 g/ml) and analyzed for their sugar
content. The [14C]arabinose content decreased in Cg-pVWEx2 treated with
BTZ043, whereas no decrease in [14C]arabinose was evident in BTZ043-
treated Cg-pVWEx2-uppS. The lanes have been grouped from different parts
of the same TLC exposure.
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vation that implicates DprE1 as being a particularly susceptible
target within cell wall biosynthesis.
BecauseM. tuberculosis and C. glutamicum share a remark-
ably similar cell wall andmany of the genes involved in cell wall
biosynthesis are syntenic, C. glutamicum represents an excel-
lent model organism for studying the molecular genetics asso-
ciated with cell wall biosynthesis inM. tuberculosis (22–26). In
this regard, we have successfully generated a panel of C. glu-
tamicummutant strains that incur lesions in cell wall arabinan
due to the loss of genes that encode specific arabinofuranosyl-
transferasess or proteins involved in the processing of DPA. C.
glutamicum::ubiA is a mutant strain that exhibits an extremely
interesting phenotype, which is a complete loss of cell wall ara-
binan and covalently attached corynomycolates (8, 9, 27). This
mutant becomes even more pertinent when we consider the
fact thatC. glutamicum is susceptible to the bactericidal activity
of BTZ043, displaying anMIC of 20 g/ml. The question must
be asked, “why is C. glutamicum, a seemingly non-arabinan
requiring member or the Corynebacterineae, susceptible to
BTZ043, which has a reportedmode of action as the blockage of
D-arabinan formation by virtue of DprE1 inhibition?”
The data in this study does not exclude the possibility that
killing results directly from toxicity associated with the accu-
mulation of the DprE1 substrate DPR. Overproduction of Cg-
UbiA could be toxic, either because of DP sequestration as we
propose or through DPR accumulation. However, simultane-
ous overproduction of Cg-UppS and Cg-UbiA should either be
lethal, if DPR accumulation is toxic, or rescue growth, if DP
sequestration is actually killing the bacilli. We attempted to
clarify this by amplifying Cg-ubiA from genomic DNA and
cloning it into the inducible vector pEKEx2, which we have
used successfully in previous studies on a number of mem-
brane-embedded arabinosyltransferases (26, 28). We obtained
a number of clones with the appropriate length, using a variety
of PCR conditions and at least three different polymerases.
However, upon sequencing different small mutations were
present resulting in at least one non-acceptable amino acid
change in our experiments.We then changed the cloning strat-
egy by using another inducible vector pCLTON2, but again
experienced similar non-acceptable mutations in Cg-ubiA. We
therefore suggest that a weak expression even under non-in-
ducing conditions is not tolerated when using an E. coli cloning
host. We then attempted direct cloning in C. glutamicum but
were again not successful in obtaining a correctly validated
gene sequence. Altogether, this points to a delicate and tight
control of Cg-ubiA expression, which is in line with the physi-
ological data obtained in our studies.
However, our study does highlight the role of UppS, a deca-
prenyl-phosphate synthase, in rescuing C. glutamicum from
the bactericidal effect of BTZ043 (Fig. 8). The implication here
being that inhibition of DprE1 becomes acutely important
when DPR begins accumulating in the cell membrane, and rep-
resents a metabolic “dead end” that halts the recycling of deca-
prenyl phosphate back into cell wall biosynthetic processes
(Fig. 8). When UppS is overexpressed in C. glutamicum, the
resultant phenotype is an increased tolerance to BTZ043 (Fig.
5). This increased tolerance can be attributed to the increased
biosynthesis of decaprenyl phosphate, which is required pri-
marily for the production of lipid II, an essential intermediate
involved in peptidoglycan biosynthesis. This data is in accord-
ance with our previous observations that although C. glutami-
cum has a cell wall with enough plasticity to dispense with
D-arabinan, it still requires peptidoglycan to protect against the
internal osmotic stress across the cytoplasmic membrane (15,
29). In this regard, a decrease in the expression of uppS from
Bacillus subtilis has been shown to confer increased suscepti-
FIGURE 7. SDS-PAGE analysis of lipoglycans extracted fromC. glutamicum-pVWEx2(Cg-pVWEx2) (A), Cg-pVWEx2 treatedwith BTZ043 (B),C. glutami-
cum-pVWEx2-uppS (Cg-pVWEx2-uppS) (C), and Cg-pVWEx2-uppS treatedwith BTZ043 (D). Cultures were grown in liquidmedia to A600 of 0.5 before the
addition of [14C]glucose and BTZ043 (20 g/ml) and growth was continued for up to 6 h.
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bility tomany late-acting cell wall antibiotics, such as-lactams
(30). However, this effect was significantly more pronounced
when experiments were repeated using fosfomycin and D-cy-
closerine, which interfere with the early stages of peptidoglycan
biosynthesis (30). In Gram-positive organisms, such as B. sub-
tilis the undecaprenyl phosphate (C55-P) is the major polypre-
nyl carrier used in the synthesis of peptidogylcan as well as
other cell wall components such as wall teichoic acids (31, 32).
Furthermore, similar effects have been demonstrated in Staph-
ylococcus aureus, whereby Targocil, an inhibitor of late-stage
cell wall teichoic acid biosynthesis, causes an accumulation of
undecaprenyl-linked intermediates, thus preventing recycling
of the undecaprenyl-phosphate lipid carrier (33).Whereas lipid
II is important for peptidoglycan biosynthesis, Corynebacteri-
neae, such asM. tuberculosis andC. glutamicum, also use deca-
prenyl phosphate in the production of DPA and decaprenyl
phosphomannose, which is directed toward the formation of
D-arabinan and lipomannan (which is the precursor to LAM),
respectively. We sought to investigate the effects of uppS over-
expression on the biosynthesis of these cell wall polysaccha-
rides when exposed to BTZ043. Our analysis of the total sugar
content from mAGP isolated from C. glutamicum-pVWEx2
revealed an overall decrease in arabinose upon treatment with
BTZ043. This result was expected because BTZ inhibits the
production of the sole decaprenyl phosphate-based arabinose
donor, DPA, which is required for biosynthesis of D-arabinan.
However, we were able to counter this effect by overexpressing
uppS, which resulted in a continued incorporation of [14C]ara-
binose intomAGPevenup toBTZ043 concentrations thatwere
0.75 MIC (Fig. 6). Similarly, examination of the LAM pool
from the BTZ043-treatedC. glutamicum-pVWEx2 strain dem-
onstrates a decrease in both LM and LAM, because both mol-
ecules employ decaprenyl phosphate-based sugar donors, in
the form of decaprenyl phosphomannose andDPA. Because we
FIGURE 8. A schematic representation of the proposed mechanism of action of BTZ on DprE1 inhibition and decaprenyl phosphate recycling. DPA
synthesis is crucial for biosynthesis of arabinan components of LAMandAGandbeginswith transfer of ribosephosphate fromphosphoribosyl pyrophosphate
(pRPP) to decaprenyl phosphate and follows the pathway where DprE1/E2 generates DPA from DPR. Treatment with BTZ043 (star) results in accumulation of
DPR (highlighted in a broken circle) stalling LAM and AG biosynthesis and a block in decaprenyl phosphate recycling. Overexpression of UppS, the prenyl
synthase (highlighted in a broken circle) causes restoration of the recycling pathway by supplementing enoughdecaprenyl phosphate for synthesis of cell wall
components.
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observe a commensurate decrease in the formation of LM and
LAM upon exposure to BTZ043, the notion that BTZ043 acts
by inhibitingDPA formation is a false dichotomy. Indeed, over-
expression of uppS restores the synthesis of both LM and LAM
lipoglycan pools in the presence of BTZ043 (Fig. 7).
Mycobacteria can develop natural resistance to BTZs due to
the occurrence of a singlemutation in the operon coding for the
Cys-387 residue in DprE1, which is substituted with an Ala or
Ser, as observed inMycobacterium avium andMycobacterium
aurum, respectively (1). BTZ043 functions as a pro-drug (34,
35) that requires reduction of the nitro group to an electrophilic
nitroso-derivative to react with the Cys-387 residue in the
active site of DprE1. This reaction is catalyzed either by DprE1
itself (36) or by other oxygen-insensitive nitroreductases (34).
Bacterial nitroreducases, such as NfnB are capable of rendering
the drug inactive by reducing the nitro group to the corre-
sponding amine as observed in case of M. smegmatis (34). In
this regard, the results obtained from this study imply that
increased expression of decaprenyl phosphate synthase (uppS)
might provide an alternative mechanism for Corynebacteri-
neae, to become resistant to BTZ. Furthermore, UppS might
also serve as an effective drug target because its role is crucial in
synthesis of a variety of mycobacterial cell wall components.
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